Abstract
The ectopic expression of telomerase1,2 in normal human cells results in an extended lifespan3,4, indicating that telomere shortening regulates the timing of cellular senescence. As telomerase expression is a hallmark of cancer, we investigated the long–term effects of forced expression of human telomerase catalytic component (hTERT) in normal human fibroblasts. In vitro growth requirements, cell–cycle checkpoints and karyotypic stability in telomerase–expressing cells are similar to those of untransfected controls. In addition, co–expression of telomerase, the viral oncoproteins HPV16 E6/E7 (which inactivate p53 and pRB) and oncogenic HRAS does not result in growth in soft agar. Thus, although ectopic expression of telomerase in human fibroblasts is sufficient for immortalization, it does not result in changes typically associated with malignant transformation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nakamura, T.M. et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955– 959 (1997).
Meyerson, M. et al. hEST2, the putative human telomerase catalytic subunit gene, is up–regulated in tumor cells and during immortalization. Cell 90, 785–795 ( 1997).
Bodnar, A.G. et al. Extension of life–span by introduction of telomerase into normal human cells. Science 279, 349 –352 (1998).
Vaziri, H. & Benchimol, S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8, 279– 282 (1998).
Shay, J.W., Wright, W.E. & Werbin, H. Defining the molecular mechanisms of human cell immortalization. Biochim. Biophys. Acta 1072, 1– 7 (1991).
Abercrombie, M. Contact inhibition in tissue culture. In Vitro 6, 128–142 (1970).
Scher, C.D. & Todaro, G.J. Selective growth of human neoplastic cells in medium lacking serum growth factor. Exp. Cell Res. 68, 479–481 (1971).
Buchovitch, K., Duffy, L.A. & Harlow, E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58, 1097–1105 (1989).
DeCaprio, J.A. et al. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58, 1085–1095 (1989).
Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B. & Craig, R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51 , 6304–6311 (1991).
Levine, A.J., Momand, J. & Finlay, C.A. The p53 tumor suppressor gene. Nature 351, 453–456 (1991).
DiLeonardo, A., Linke, S.P., Clarkin, K. & Wahl, G.M. DNA damage triggers a prolonged p53–dependent G1 arrest and long term induction of Cip1 in normal human fibroblasts. Genes Dev. 8, 2540–2551 (1994).
Brown, J.P., Wei, W. & Sedivy, J.M. Bypass of senescence after disruption of p21Cip1/Waf1 gene in normal diploid human fibroblasts. Science 277, 831–834 (1997).
White, A.E., Livanos, E.M. & Tlsty, T.D. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev. 8, 666–677 ( 1994).
Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D. & Lowe, S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593–602 (1997).
Dimri, G.P. et al. A biomarker that identifies senscent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363–9367 (1995).
Land, H., Parada, L.F. & Weinberg, R.A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304, 596–602 (1983).
Newbold, R.F. & Overell, R.W. Fibroblast immortality is a prerequisite for transformation by EJ c–Ha–ras oncogene. Nature 304, 648–651 ( 1983).
Sager, R. Senescence as a mode of tumor suppression. Environ. Health Perspect. 93, 59–62 ( 1991).
Nowell, P.C. & Croce, C.M. Cytogenetics of neoplasia. in Development and Recognition of the Transformed Cell (eds Greene, M.I. & Hamaoka, T.) 1–19 (Plenum, New York, 1987).
Honda, T. et al. Spontaneous immortalization of cultured skin fibroblasts obtained from a high–dose atomic bomb survivor. Mutat. Res. 354, 15–26 ( 1996).
Saksela, E. & Moorhead, P.S. Aneuploidy in the degenerative phase of serial cultivation of human cell strains. Proc. Natl Acad. Sci. USA 50, 390–395 ( 1963).
Benn, P.A. Specific chromosome abberations in senescent fibroblast cell lines derived from human embryos. Am. J. Hum. Genet. 28, 465–473 (1976).
Halbert, C.L., Demers, G.W. & Galloway, D.A. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J. Virol. 66, 2125–2134 ( 1992).
Holt, S.E., Gollahon, L.S., Willingham, T., Barbosa, M.S. & Shay, J.W. p53 levels in human mammary epithelial cells expressing wild–type and mutant human papilloma virus type 16 (HPV–16) E6 proteins: relationship to reactivation of telomerase and immortalization. Inter. J. Oncol. 8, 263 –270 (1996).
Shay, J.W., Tomlinson, G., Piatyszek, M.A. & Gollahon, L.S. Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li–Fraumeni syndrome. Mol. Cell. Biol. 15, 425–432 (1995).
Holt, S.E., Aisner, D.L., Shay, J.W. & Wright, W.E. Lack of cell cycle regulation of telomerase activity in human cells. Proc. Natl Acad. Sci. USA 94, 10687–10692 (1997).
Clark, G.J., Cox, A.D., Graham, S.M. & Der, C.J. in Methods in Enzymology (eds Balch, W.E., Der, C.J. & Hall, A.) 395– 412 (Academic Press, San Diego, 1995).
Gustashaw K.M. in The AGT Cytogenetics Laboratory Manual (eds Barch, M.J., Knutsen, T. & Spurbeck, J.L.) 259–324 (Lippincott–Raven, Philadelphia, 1997).
Acknowledgements
We acknowledge J. Rohde, M. Liao, D. Cohen, J. Doolittle, S. Donovan and S. Patel for excellent technical assistance. This work was supported in part by the National Institutes of Aging (AG07992), the National Cancer Institute (CA71443) and Geron Corporation. C.P.M. is supported by The Robert Wood Johnson Foundation Minority Medical Faculty Development Program. J.W.S. is an Ellison Medical Foundation Senior Scholar. S.E.H. was supported by a postdoctoral fellowship from the National Institute of Aging.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Morales, C., Holt, S., Ouellette, M. et al. Absence of cancer–associated changes in human fibroblasts immortalized with telomerase. Nat Genet 21, 115–118 (1999). https://doi.org/10.1038/5063
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/5063
This article is cited by
-
Initiation of Cancer: The Journey From Mutations in Somatic Cells to Epigenetic Changes in Tissue-resident VSELs
Stem Cell Reviews and Reports (2024)
-
A robust reprogramming strategy for generating hepatocyte-like cells usable in pharmaco-toxicological studies
Stem Cell Research & Therapy (2023)
-
The other side of the coin: mesenchymal stromal cell immortalization beyond evasion of senescence
Human Cell (2023)
-
EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells
BMC Cancer (2021)
-
Cryo-EM structures tell a tale of two telomerases
Nature Structural & Molecular Biology (2021)